We are live on ! Find out more
REPL icon

Replimune Group

99 hedge funds and large institutions have $1.05B invested in Replimune Group in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

7.22% more ownership

Funds ownership: 75.58%82.8% (+7.2%)

0% more capital invested

Capital invested by funds: $1.05B → $1.05B (+$2.33M)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

2% less funds holding

Funds holding: 10199 (-2)

Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
11
Increased
39
Reduced
30
Closed
12
Calls
Puts
Net Calls
Net Calls Change

REPL Hedge Fund Activity: Q4 2021 in Review

99 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2021, worth a combined $1.05B — up 0.22% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of REPL and 11 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 39 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $13.2M. The largest seller was State Street, cutting an estimated $10.6M.

  • 99 institutional investors held Replimune Group (REPL) as of Q4 2021, down from 101 in Q3 2021.
  • Funds reported $1.05B of Replimune Group stock for Q4 2021, up 0.22% quarter-over-quarter.
  • 11 funds opened new Replimune Group positions in Q4 2021 and 12 closed out, a net change of -1 holder.
  • The largest Replimune Group buyer in Q4 2021 was Baker Bros. Advisors, an estimated $13.2M added.
  • The largest Replimune Group seller in Q4 2021 was State Street, an estimated $10.6M sold.

Based on aggregated 13F filings for Q4 2021.